These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 15185840)

  • 1. Effects of kava (Kava-kava, 'Awa, Yaqona, Piper methysticum) on c-DNA-expressed cytochrome P450 enzymes and human cryopreserved hepatocytes.
    Zou L; Henderson GL; Harkey MR; Sakai Y; Li A
    Phytomedicine; 2004; 11(4):285-94. PubMed ID: 15185840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kava does not display metabolic toxicity in a homogeneous cellular assay.
    Zou L; Harkey MR; Henderson GL; Dike LE
    Planta Med; 2004 Apr; 70(4):289-92. PubMed ID: 15095141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of cytochrome P450 3A4 by extracts and kavalactones of Piper methysticum (Kava-Kava).
    Unger M; Holzgrabe U; Jacobsen W; Cummins C; Benet LZ
    Planta Med; 2002 Dec; 68(12):1055-8. PubMed ID: 12494328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of human cytochrome P450 activities by kava extract and kavalactones.
    Mathews JM; Etheridge AS; Black SR
    Drug Metab Dispos; 2002 Nov; 30(11):1153-7. PubMed ID: 12386118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extracts and kavalactones of Piper methysticum G. Forst (kava-kava) inhibit P-glycoprotein in vitro.
    Weiss J; Sauer A; Frank A; Unger M
    Drug Metab Dispos; 2005 Nov; 33(11):1580-3. PubMed ID: 16051732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of a dry extract from milk thistle (Silybum marianum) for interference with human liver cytochrome-P450 activities.
    Doehmer J; Weiss G; McGregor GP; Appel K
    Toxicol In Vitro; 2011 Feb; 25(1):21-7. PubMed ID: 20828605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of platelet MAO-B by kava pyrone-enriched extract from Piper methysticum Forster (kava-kava).
    Uebelhack R; Franke L; Schewe HJ
    Pharmacopsychiatry; 1998 Sep; 31(5):187-92. PubMed ID: 9832350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic and pharmacodynamic drug interactions with Kava (Piper methysticum Forst. f.).
    Anke J; Ramzan I
    J Ethnopharmacol; 2004 Aug; 93(2-3):153-60. PubMed ID: 15234747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kavalactones fail to inhibit alcohol dehydrogenase in vitro.
    Anke J; Fu S; Ramzan I
    Phytomedicine; 2006 Feb; 13(3):192-5. PubMed ID: 16428028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of herbal components on cDNA-expressed cytochrome P450 enzyme catalytic activity.
    Zou L; Harkey MR; Henderson GL
    Life Sci; 2002 Aug; 71(13):1579-89. PubMed ID: 12127912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, in vitro, reactivity, and identification of 6-phenyl-3-hexen-2-one in human urine after kava-kava (Piper methysticum) ingestion.
    Zou L; Harkey MR; Henderson GL
    Planta Med; 2005 Feb; 71(2):142-6. PubMed ID: 15729622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytochrome P450 enzyme levels in HepG2 cells and cryopreserved primary human hepatocytes and their induction in HepG2 cells.
    Westerink WM; Schoonen WG
    Toxicol In Vitro; 2007 Dec; 21(8):1581-91. PubMed ID: 17637504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Final report on the safety assessment of Piper methysticum leaf/root/stem extract and Piper methysticum root extract.
    Robinson V; Bergfeld WF; Belsito DV; Klaassen CD; Marks JG; Shank RC; Slaga TJ; Snyder PW; ; Andersen FA
    Int J Toxicol; 2009; 28(6 Suppl):175S-88S. PubMed ID: 19966149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of various Piper methysticum cultivars with CNS receptors in vitro.
    Dinh LD; Simmen U; Bueter KB; Bueter B; Lundstrom K; Schaffner W
    Planta Med; 2001 Jun; 67(4):306-11. PubMed ID: 11458444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A UHPLC-UV Method Development and Validation for Determining Kavalactones and Flavokavains in
    Tang Y; Fields C
    Molecules; 2019 Mar; 24(7):. PubMed ID: 30934989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative Determination of Lactones in Piper methysticum (Kava-Kava) by Supercritical Fluid Chromatography.
    Murauer A; Ganzera M
    Planta Med; 2017 Aug; 83(12-13):1053-1057. PubMed ID: 28095587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mangifera indica L. extract and mangiferin modulate cytochrome P450 and UDP-glucuronosyltransferase enzymes in primary cultures of human hepatocytes.
    Rodeiro I; José Gómez-Lechón M; Perez G; Hernandez I; Herrera JA; Delgado R; Castell JV; Teresa Donato M
    Phytother Res; 2013 May; 27(5):745-52. PubMed ID: 22815239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclooxygenase enzyme inhibitory compounds with antioxidant activities from Piper methysticum (kava kava) roots.
    Wu D; Yu L; Nair MG; DeWitt DL; Ramsewak RS
    Phytomedicine; 2002 Jan; 9(1):41-7. PubMed ID: 11924763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and disposition of the kavalactone kawain: interaction with kava extract and kavalactones in vivo and in vitro.
    Mathews JM; Etheridge AS; Valentine JL; Black SR; Coleman DP; Patel P; So J; Burka LT
    Drug Metab Dispos; 2005 Oct; 33(10):1555-63. PubMed ID: 16033948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation and synthesis of TNF-alpha release inhibitors from Fijian kawa (Piper methysticum).
    Hashimoto T; Suganuma M; Fujiki H; Yamada M; Kohno T; Asakawa Y
    Phytomedicine; 2003 May; 10(4):309-17. PubMed ID: 12809361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.